Navigation Links
Lung Cancer Alliance Hails Massachusetts State Senator for Taking Lead on Lung Cancer
Date:1/15/2009

For Second Straight Year, Legislation Introduced to Fund Lung Cancer Research

BOSTON, Jan. 15 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance (LCA) hailed Senator Susan Fargo (D-3rd Middlesex), the Senate Chair of the Joint Committee on Public Health, for once again introducing comprehensive legislation that creates a trust fund for lung cancer research.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO)

"Now is the time for positive change for lung cancer in Massachusetts," said Joanne O'Connor, LCA-Massachusetts (LCA-MA) Co-chair. "On behalf of those touched by lung cancer in Massachusetts, we thank Senator Fargo for her continued leadership in addressing the critical need for increased lung cancer research."

Lung cancer is the leading cause of cancer deaths nationally and in Massachusetts. Lung cancer claims more lives each year than breast, prostate, and colon cancers--combined. In 2008, an estimated 4,930 Massachusetts citizens were diagnosed with lung cancer and 3,600 were lost to the disease. Over 70% are diagnosed at a late stage accounting for the low 15% survival rate.

"There are too few opportunities for the research community to tackle lung cancer and make an impact on survival rates," said Senator Fargo. "This legislation is intended to drive lung cancer research forward in many different areas as well as to allow researchers to find innovative new methods of diagnosing and treating the disease."

"This bill provides the funding needed to institute innovative lung cancer screening programs for those at high risk throughout the state, especially rural and underserved populations," said Diane Legg, lung cancer survivor and LCA-MA Co-chair. "In addition, the bill enhances research that has been lacking on targeted therapies, chemoprevention, and disparities."

The bill, introduced this week, establishes screening programs for the high risk population, promotes the development of new diagnostic and screening technologies for lung cancer, supports research into the disparities surrounding lung cancer incidence and mortality rates, and supports research to discover cures through the development of chemoprevention and targeted therapies.

"I commend Senator Fargo for her work in raising awareness of lung cancer as an under-recognized and under-funded health priority," Yolonda Colson, MD, PhD, Associate Professor of Surgery, Division of Thoracic Surgery and Director, Women's Lung Cancer Program at Brigham and Women's Hospital.

"We are committed to working with Senator Fargo, other members of the state legislature, public health organizations and all who share our goal of reducing lung cancer's mortality rates through increased research funding," O'Connor said.

Lung Cancer Alliance (www.LungCancerAlliance.org) is the only national non-profit organization dedicated exclusively to patient support and advocacy for those living with or at risk for lung cancer. Lung Cancer Alliance is committed to leading the movement to reverse decades of stigma and neglect by empowering those with or at risk for the disease, elevating awareness and changing health policy.

    Media Contact:
    Joanne O'Connor
    joconnor@lungcanceralliance.org
    781-335-4727


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: